US-based health technology solutions provider Cytta has signed a joint venture (JV) agreement with Canadian cardiovascular devices firm CardioComm Solutions for a remote patient monitoring platform, VeriSmartPhone.
As per the agreement, CardioComm’s HeartCheck and GEMS ECG technologies will be integrated with Cytta’s EvrCare Health and Wellness Platform to implement the web-based VeriSmartPhone.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The EvrCare solution builds on Cytta’s new Superior Utilisation of Processing for Error Resilience (SUPER) video and data compression/decompression solution designed to minimise data file size, improve data transfer speed, and decrease telemedicine communication costs.
CardioComm’s ECG solutions software accepts raw data from any device through Bluetooth and generates an accurate ECG trace with information on recording, review and report.
The EvrCare telemedicine platform with CardioComm ECG analysis tools will be used to manage all reports, findings and related patient information to deliver the ECG findings and other EvrCare related peripherals used for monitoring.
“CardioComm’s ECG solutions software accepts raw data from any device through Bluetooth and generates an accurate ECG trace with information on recording, review and report.”
Intended for single and group users, the integrated solution is expected to allow real-time tracking, evaluation and management of biometric information from all connected health and wellness devices.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataCytta also intends to add a doctor-directed platform that will enable caregivers and insurers to prescribe devices to improve long-term care for people who are at high risk of disease onset or have chronic medical conditions.
Planned to be initially launched in the US, the EvrCare VeriSmartPhone platform is intended to eliminate technological, workflow and infrastructure challenges associated with remote patient monitoring solutions for mobile cardiac telemetry, arrhythmia and prolonged QT interval screening.
The technology is also expected to be useful for in-hospital and in-clinic services, as well as pre/post-hospital surgery discharge monitoring.
